- Mapping genomic variation in African populations
- Identifying gene-drug pairs that are of pharmacogenomics importance
- Integration of information on host genetic variation and epigenetics to inform on strategies for improve drug treatment response
- Development of pharmacogenomics tests
- Training and supporting researchers and/ or healthcare professionals on pharmacogenomics, its applications and utility in clinical decision making
- Advocacy on pharmacogenomics and its utility in the reduction of drug associated side effects